Transition Therapeutics, Inc. (TTH) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Transition Therapeutics, Inc. Company Snapshot

Business Description:

Transition Therapeutics, Inc. operates in the Medicinals and botanicals sector. Transition Therapeutics Inc. (Transition) is a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets. The Company's technologies in development include ELND005 (AZD-103) for the treatment of Alzheimer's disease; TT-301 and TT-302, which have a therapeutic effect on diseases, including arthritis, Alzheimer's disease, traumatic brain injury, intracerebral haemorrhage, and others, and TT401/402 for the treatment of diabetes. On June 30, 2010, Transition announced the initiation of a Phase I clinical study of TT-301. In March 2010, the Company acquired the rights to a series of preclinical compounds from Eli Lilly and Company (Lilly) in the area of diabetes. In our complete report available for purchase the company is compared to: Ibex Technologies Inc., Isotechnika Pharma Incorporation and YM Biosciences Inc.

Transition Therapeutics, Inc.

Stock Data:

Recent Stock Performance:

Current Price (2/2/2012): 1.56
(Figures in Canadian Dollars)

1 Week	4.0%	13 Weeks	4.0%

4 Weeks	-3.7%	52 Weeks	-24.3%

Transition Therapeutics, Inc. Key Data:

Ticker:	TTH	Country:	CANADA

Exchanges:	TOR	Major Industry:	Miscellaneous

		Sub Industry:	Medical Services

2011 Sales	29,671,150 (Year Ending Jan 2012).	Employees:	20

Currency:	Canadian Dollars	Market Cap:	41,997,231

Fiscal Yr Ends:	June	Shares Outstanding:	26,921,302

Share Type:	Common	Closely Held Shares:	12,159,006

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.